<p>The cumulative incidence of dementia estimated by Kaplan–Meier method for patients with oxybutynin, solifenacin or tolterodine exposure</p
<p>Examination of the risk factors of dementia in terms of the antidepressant cDDD and its side effe...
The effects of oxybutynin, solifenacin and tolterodine on dementia risk in patients with diabetes me...
<p>Cumulative Kaplan–Meier estimates of all cause and cardiovascular mortality according the circula...
<p>Five-year cumulative incidence of dementia by baseline age and <i>APOE</i>-e4 dose.</p
<p>Kaplan–Meier curves for cumulative incidence of major cardiovascular events in normoalbuminuria a...
<p>(a) presents a comparison of the cumulative incidence of dementia for the ARD and non-ARD patient...
<p>Cumulative incidence curves of dementia for groups with and without tension-type headache.</p
<p>Incidence of dementia and Cox model results for the ARD patient group and the comparison group.</...
The Kaplan-Meier curves with cumulative hazards showed the significantly higher incidence of overall...
Kaplan-Meier curves with 95% confidence intervals of developing any dementia among patients with den...
<p>Cumulative incidence for osteonecrosis by osteoporosis and bisphosphonates (Kaplan-Meier analysis...
Second-line treatment for overactive bladder (OAB), consists of muscarinic antagonists or β-3 agonis...
<p>Incidence and hazard ratio of dementia in the patients with AKI and the comparison cohort.</p
<p>All-cause dementia by A) use and B) defined daily dose (DDD) of proton pump inhibitors (PPIs).</p
OBJECTIVES: To estimate the association between duration and level of exposure to different classes ...
<p>Examination of the risk factors of dementia in terms of the antidepressant cDDD and its side effe...
The effects of oxybutynin, solifenacin and tolterodine on dementia risk in patients with diabetes me...
<p>Cumulative Kaplan–Meier estimates of all cause and cardiovascular mortality according the circula...
<p>Five-year cumulative incidence of dementia by baseline age and <i>APOE</i>-e4 dose.</p
<p>Kaplan–Meier curves for cumulative incidence of major cardiovascular events in normoalbuminuria a...
<p>(a) presents a comparison of the cumulative incidence of dementia for the ARD and non-ARD patient...
<p>Cumulative incidence curves of dementia for groups with and without tension-type headache.</p
<p>Incidence of dementia and Cox model results for the ARD patient group and the comparison group.</...
The Kaplan-Meier curves with cumulative hazards showed the significantly higher incidence of overall...
Kaplan-Meier curves with 95% confidence intervals of developing any dementia among patients with den...
<p>Cumulative incidence for osteonecrosis by osteoporosis and bisphosphonates (Kaplan-Meier analysis...
Second-line treatment for overactive bladder (OAB), consists of muscarinic antagonists or β-3 agonis...
<p>Incidence and hazard ratio of dementia in the patients with AKI and the comparison cohort.</p
<p>All-cause dementia by A) use and B) defined daily dose (DDD) of proton pump inhibitors (PPIs).</p
OBJECTIVES: To estimate the association between duration and level of exposure to different classes ...
<p>Examination of the risk factors of dementia in terms of the antidepressant cDDD and its side effe...
The effects of oxybutynin, solifenacin and tolterodine on dementia risk in patients with diabetes me...
<p>Cumulative Kaplan–Meier estimates of all cause and cardiovascular mortality according the circula...
DOI
Add to ORKG